July 30, 2019
Weil advised Willis Towers Watson in $1.3 billion acquisition of TRANZACT. Willis Towers Watson is a global advisory, broking and solutions company and TRANZACT is a direct-to-consumer health care organization that links individuals to U.S. insurance carriers. TRANZACT will operate as an integral part of Willis Towers Watson’s Benefits Delivery and Administration business, which focuses on the development and delivery of administrative solutions for employers, employees and retirees.
Weil previously advised Willis Group Holdings in its $18 billion merger with Towers Watson & Co. in 2015.
The Weil team was led by Mergers & Acquisitions partner Michael J. Aiello and included Mergers & Acquisitions partner Jackie Cohen and Mergers & Acquisitions associates Rachel Shapiro, Alex Chelesnik and Michael Chenkin. The team also included Tax Head Joe Pari and International Tax Head Devon Bodoh; Executive Compensation & Benefits Head Paul Wessel; Structured Finance & Derivatives partner Shawn Kodes; Technology & IP Transactions Head Michael Epstein; Banking & Finance partner Courtney Marcus; Real Estate partner David Herman; Antitrust/Competition partner Jeffrey Perry; Labor and Employment partner Nicholas Pappas; Privacy & Cybersecurity Co-Head Randi Singer; Environmental counsel Thomas Goslin; Antitrust/Competition counsel Vadim Brusser; Tax associates Eric Remijan and Sidney Chiang; Executive Compensation & Benefits associates Akansha Mishra and Lauren Sawyer (Not Yet Admitted in New York); Structured Finance & Derivatives associate Matthew Nemeth; Technology & IP Transactions/Privacy associates Maryann Thompson and Elisabeth Sperle; Banking & Finance associates Vynessa Nemunaitis and Veronica Bonhamgregory; Antitrust/Competition associate Natalie Hayes; and Employment Litigation associate Justin DiGennaro.